Z-2715-2026 Class II Ongoing

Recalled by Biomerieux Inc — Hazelwood, MO

FDA device recall Z-2715-2026 was initiated by Biomerieux Inc on Jun 4, 2026 and is designated Class II. Reason for recall: Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures. The recall status is ongoing. Affected quantity: 45,900 cards.

Recall details

Product Type
Devices
Report Date
Jul 15, 2026
Initiation Date
Jun 4, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
45,900 cards

Product description

VITEK 2 AST-N447 TEST KIT Product reference 424620

Reason for recall

Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

Distribution pattern

International distribution to the countries of Belgium and the Netherlands.

Code information

Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2715-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2715-2026. Report a data issue: hello@regdatalab.com.